NTRB
Nutriband IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$41.21M
P/E Ratio
—
EPS
$-2.56
Beta
1.93
52W High
$11.68
52W Low
$3.21
50-Day MA
$3.75
200-Day MA
$4.95
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
370.37
PEG Ratio
—
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
Fundamentals
| Revenue (TTM) | $1.80M |
| Gross Profit (TTM) | 511,130 |
| EBITDA | $-7.99M |
| Operating Margin | -289.40% |
| Return on Equity | -145.70% |
| Return on Assets | -78.20% |
| Revenue/Share (TTM) | $0.15 |
| Book Value | $0.49 |
| Price-to-Book | 6.88 |
| Price-to-Sales (TTM) | 22.86 |
| EV/Revenue | 20.77 |
| EV/EBITDA | -4.55 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -35.10% |
| Shares Outstanding | $12.16M |
| Float | $5.28M |
| % Insiders | 74.50% |
| % Institutions | 3.08% |
Historical Volatility
HV 10-Day
35.66%
HV 20-Day
49.62%
HV 30-Day
55.66%
HV 60-Day
54.74%
HV Rank
20.6%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026